[HTML][HTML] Bioactive compounds and nanodelivery perspectives for treatment of cardiovascular diseases

RK Sindhu, A Goyal, E Algın Yapar, S Cavalu - Applied Sciences, 2021 - mdpi.com
Bioactive compounds are comprised of small quantities of extra nutritional constituents
providing both health benefits and enhanced nutritional value, based on their ability to …

[HTML][HTML] Recent developments in nanomaterials-based drug delivery and upgrading treatment of cardiovascular diseases

NA Mohamed, I Marei, S Crovella… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …

Nanomedicine applied to cardiovascular diseases: latest developments

VM Martín Giménez, DE Kassuha… - Therapeutic …, 2017 - journals.sagepub.com
Cardiovascular diseases are a major cause of disability and they are currently responsible
for a significant number of deaths in a large percentage of the world population. A large …

The application of nanomaterials in cardiovascular diseases: A review on drugs and devices

SM Dizaj, AA Rad, N Safaei… - … of Pharmacy & …, 2019 - journals.library.ualberta.ca
Cardiovascular diseases (CVDs) are still one of the main causes of death. In recent years,
nanotechnology has offered new materials and strategies for more effective and safe …

Recent Advancement in Nanotechnology based Drug Delivery for the Management of Cardiovascular disease.

A Ullah, M Ullah, SI Lim - Current problems in cardiology, 2024 - Elsevier
Cardiovascular diseases (CVDs) constitute a predominant cause of both global mortality
and morbidity. To address the challenges in the early diagnosis and management of CVDs …

[PDF][PDF] Nanomedicine for the diagnosis and treatment of cardiovascular disease: current status and future perspective

E Gundogdu, Z Senyigit, D Ilem-Ozdemir - Cardiovascr Dis I, 2014 - academia.edu
Cardiovascular disease (CVD) encompasses all pathologies of the heart or circulatory
system, including coronary heart disease, peripheral vascular disease and stroke …

[HTML][HTML] Nanomaterial-based drug targeted therapy for cardiovascular diseases: ischemic heart failure and atherosclerosis

MȘC Haba, DN Șerban, L Șerban, IM Tudorancea… - Crystals, 2021 - mdpi.com
Cardiovascular diseases (CVDs) represent the most important epidemic of our century, with
more than 37 million patients globally. Furthermore, CVDs are associated with high …

[HTML][HTML] Cardiovascular therapy through nanotechnology–how far are we still from bedside?

I Cicha, CD Garlichs, C Alexiou - European Journal of Nanomedicine, 2014 - degruyter.com
Recent years brought about a widespread interest in the potential applications of
nanotechnology for the diagnostics and the therapy of human diseases. With its promise of …

[HTML][HTML] Theranostic nanomedicines for the treatment of cardiovascular and related diseases: current strategies and future perspectives

N Manners, V Priya, AK Mehata, M Rawat, S Mohan… - Pharmaceuticals, 2022 - mdpi.com
Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases

T Li, W Liang, X Xiao, Y Qian - International journal of …, 2018 - Taylor & Francis
Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …